This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Acute Myelocytic Leukemia or Myelodysplastic Syndrome
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Assessment of efficacy of azacitidine to prevent a relapse

Provided treatments

  • Drug: Azacitidine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01462578. The sponsor of the trial is Technische Universität Dresden and it is looking for 93 volunteers for the current phase.
Official trial title:
Treatment of Patients With MDS or AML With an Impending Hematological Relapse With Azacitidine (Vidaza)